<HTML>
<HEAD>
<TITLE>AOD Thesaurus Annotated Hierarchy: chemical substances by structure ZT ZT12.2</TITLE>
<META
Name="Description"sA Guide to Concepts and Terminology in Substance Abuse and Addiction">
</META>
<META
Name="Keywords"
Content="classification thesaurus glossary dictionary definition subject heading list ontology vocabulary knowledge structure knowledge organization terminology concept">
</META>
</HEAD>
<body bgcolor="#FFFFFF">
<CENTER><B><BIG>AOD Thesaurus.&nbsp;&nbsp;Annotated Hierarchy.&nbsp;&nbsp;chemical substances by structure.&nbsp;&nbsp;ZT - ZT12.2</BIG></B></Center>
<CENTER><A HREF="aodob.htm#Z">b-out</A>&nbsp;&nbsp;To Broad Outline&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#ZT">d-out</A>&nbsp;&nbsp;To Detailed Outline&nbsp;&nbsp;&nbsp;&nbsp;
<A HREF="aodhqz.htm">qh</A>&nbsp;&nbsp;To Quick Hierarchy</CENTER>
<CENTER><A HREF="aodhnzr.htm">Previous</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodhnzu.htm">Next</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodwsrch.htm">Search</A></CENTER><BR><BR>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT"><B><BIG>ZT</BIG></B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B><BIG>heterocyclic compounds</BIG></B>&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#ZT"><SMALL>d-out</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">BT</TD><TD>+ZDe organic compounds &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZD"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZD"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT2"><B>ZT2</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>heterocyclic acid</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">NT</TD><TD>+ZP18.4e nicotinic acid &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP18-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP18-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ8.2e meperidine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT6.10.4e indoleacetic acid &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-10-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT2-2">ZT2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>isonipecotic acid&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">BT</TD><TD>+ZT4.20e piperidine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-20"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-20"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT2-4">ZT2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>nipecotic acid&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4"><B>ZT4</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>1-ring heterocyclic compounds</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-2">ZT4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>azepine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-2-2">ZT4.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pentylenetetrazole&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YW8.6 convulsants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW8-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-4">ZT4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>azocine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-4-2">ZT4.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>cyclazocine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-6">ZT4.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>azole&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-6-2">ZT4.6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>tetrazole&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-6-2-2">ZT4.6.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>tetrazolium salt&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-6-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-6-4">ZT4.6.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>chlormethiazole&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">ST</TD><TD> clomethiazole </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP4.6e alcohol withdrawal agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-6-6">ZT4.6.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>atipamezole&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-6-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YP4.2e anti-alcohol-intoxication agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-6-8">ZT4.6.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nitrefazole&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-6-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">ST</TD><TD> 2-methyl-4-nitro-1-(4-nitrophenyl) imidazole </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP4.8.8e alcohol deterrents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-8">ZT4.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>dioxin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-8-2">ZT4.8.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>tetrachlorodibenzodioxin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-10">ZT4.10</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>fentanyl&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">BT</TD><TD>+BT6.4.10.2 schedule II opiates &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-4-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-4-10-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.2e narcotic analgesics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ8 phenylpiperidine derivative opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ18e synthetic opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ18"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ18"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-12">ZT4.12</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>furan&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-12-2">ZT4.12.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nitrofuran&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-12-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YT12.2 urinary anti-infective agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT12-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-12-2-2">ZT4.12.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>furazolidone&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-12-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YD8.2 ADH antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YD8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YD8-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-12-2-4">ZT4.12.2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nitrofurantoin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-12-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-12-4">ZT4.12.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>ranitidine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-12-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YT10.8 antiulcer agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT10-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT10-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YT10.14 antisecretory agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT10-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT10-14"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV6.4.4e histamine H2 receptor blockaders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-4-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-14">ZT4.14</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>imidazoles&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-14"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-14-2">ZT4.14.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>clonidine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-14-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Originally developed as an antihypertensive medicine, clonidine has been found to be an effective nonopiate drug for controlling withdrawal from opiates and opioids. Subjects experience only mild
   discomfort detoxifying with clonidine, and its use has been proposed as a transition drug to bridge the gap in moving addicts from methadone treatment to antagonist (e.g., naltrexone) treatment.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP4.6e alcohol withdrawal agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.8.12.8 agents for alcohol-concurrent anxiety &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-12-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-12-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.8.12.10 agents for alcohol-related cognitive impairment &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-12-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-12-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP8 anti-nicotine-abuse agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP12.4 opiate detoxification agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP12-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP12-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP12.6 opiate withdrawal agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP12-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP12-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YT8.8 antihypertensive agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-14-4">ZT4.14.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>creatinine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-14-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">RT</TD><TD><TT>&nbsp;</TT>HF2e urinalysis &nbsp;&nbsp;&nbsp;<A HREF="aodhqha.htm#HF2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnha.htm#HF2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-14-6">ZT4.14.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>hydantoin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-14-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YW4.6e anticonvulsants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-14-6-2">ZT4.14.6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>phenytoin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-14-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YP4.6.12 anti-alcohol-related-seizures agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6-12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YT8.2 antiarrhythmia agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-14-6-4">ZT4.14.6.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>thiohydantoin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-14-6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-14-6-4-2">ZT4.14.6.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>phenylthiohydantoin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-14-6-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-14-8">ZT4.14.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nitroimidazole&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-14-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-14-8-2">ZT4.14.8.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>metronidazole&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-14-8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YD8.2 ADH antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YD8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YD8-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-14-10">ZT4.14.10</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>ondansetron&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-14-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YP4.8.2.8 narcotic antagonist anti-alcohol-craving agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-2-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-2-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV6.6.2e serotonin uptake inhibitors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-6-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-14-12">ZT4.14.12</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>phentolamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-14-12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YD8.2 ADH antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YD8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YD8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YT8.8 antihypertensive agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV12.2e alpha-adrenergic receptor blockaders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV12-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-14-14">ZT4.14.14</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>tolazoline&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-14-14"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YV12.2e alpha-adrenergic receptor blockaders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV12-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-16">ZT4.16</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>oxazole&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-16"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-16-2">ZT4.16.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>isoxazoles&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-16-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-16-2-2">ZT4.16.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-16-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> AMPA </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-16-4">ZT4.16.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pemoline&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-16-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+BT6.8.4 schedule IV CNS stimulants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW8e CNS stimulants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-16-4-2">ZT4.16.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>magnesium pemoline&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-16-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YP10.8.10 agents for cocaine-concurrent mental disorders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP10-8-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP10-8-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP10.8.10.6 agents for cocaine-related cognitive impairment &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP10-8-10-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP10-8-10-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW8e CNS stimulants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-16-6">ZT4.16.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>trimethadione&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-16-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YW4.6e anticonvulsants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-18">ZT4.18</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>piperazine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-18"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZT8.16.2.2e flupenthixol &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-16-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT8-16-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-18-2">ZT4.18.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>amperozide&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-18-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
<TR><TD WIDTH="29%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>A derivative of piperazine with effects on stress-induced orders.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-18-4">ZT4.18.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>trazodone&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-18-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YP10.8.6 cocaine blockers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP10-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP10-8-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP10.8.10.2 agents for cocaine-concurrent depression &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP10-8-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP10-8-10-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV6.6.2e serotonin uptake inhibitors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-6-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-20">ZT4.20</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>piperidine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-20"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>BF6e phencyclidine &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BF6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BF6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT2.2 isonipecotic acid &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-20-2">ZT4.20.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>paroxetine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-20-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YV6.6.2e serotonin uptake inhibitors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-6-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-20-4">ZT4.20.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>penfluridol&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-20-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YW4.10.2e antipsychotic tranquilizers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-10-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-20-6">ZT4.20.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>perhexiline&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-20-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YT8.14e calcium channel blockers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-14"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-20-8">ZT4.20.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>piperidone&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-20-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZJ2.10.10.6.2.2e thalidomide &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-10-10-6-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-10-10-6-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-20-8-2">ZT4.20.8.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>cycloheximide&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-20-8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YQ4.14.6 antifungal antibiotics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YQ4-14-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YQ4-14-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-20-8-4">ZT4.20.8.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>glutethimide&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-20-8-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A nonbarbiturate hypnotic used in the treatment of insomnia.  Physical and psychological dependence on this drug have occurred.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> Doriden </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.4.4 schedule II CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.4e nonbarbiturate sedative-hypnotics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-22">ZT4.22</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>pyran&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-22"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-22-2">ZT4.22.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>patulin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-22-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YX2.12 mycotoxins &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX2-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YX2-12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YX4e carcinogens &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YX4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-24">ZT4.24</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>pyrazole&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-24"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-24-2">ZT4.24.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>4-methylpyrazole&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-24-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-24-4">ZT4.24.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>antipyrine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-24-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YQ2.2 nonsteroidal anti-inflammatory drugs &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YQ2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YQ2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YR2.2 nonnarcotic analgesics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YR2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YR2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26">ZT4.26</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>pyridine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-2">ZT4.26.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>aminopyrine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>BD2e nicotine &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BD2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BD2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-2-2">ZT4.26.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pyrilamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YV6.4.2e histamine H1 receptor blockaders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-2-4">ZT4.26.2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>tripelennamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>An antihistamine that has recently come into use in combination with pentazocine as a substitute for heroin.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YV6.4.2e histamine H1 receptor blockaders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-2-6">ZT4.26.2.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>dihydropyridine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-2-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZP18.4.4e nimodipine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP18-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP18-4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP4.6e alcohol withdrawal agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-2-6-2">ZT4.26.2.6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>Bay K 8644&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-2-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YT8.12e calcium channel agonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZP18.4e nicotinic acid &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP18-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP18-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-2-6-4">ZT4.26.2.6.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>isradipine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-2-6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YT8.8 antihypertensive agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YT8.14e calcium channel blockers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-14"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-2-6-6">ZT4.26.2.6.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nitrendipine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-2-6-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YT8.8 antihypertensive agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YT8.14e calcium channel blockers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-14"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-2-8">ZT4.26.2.8</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>isonicotinic acid&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-2-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>ZF6.6e isoniazid &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZF6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZF6-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-2-10">ZT4.26.2.10</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nifedipine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-2-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YP4.6e alcohol withdrawal agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YT8.14e calcium channel blockers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-14"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-4">ZT4.26.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pheniramine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-4-2">ZT4.26.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>brompheniramine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-4-2-2">ZT4.26.4.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>zimelidine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-4-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">ST</TD><TD> zimeldine </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP4.8.2.2e serotonergic anti-alcohol-craving agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV6.6.2e serotonin uptake inhibitors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW6e antidepressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-4-2-2-2">ZT4.26.4.2.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>norzimelidine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-4-2-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD><TD WIDTH="5%">BT</TD><TD>+YP4.8.2.2e serotonergic anti-alcohol-craving agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-6">ZT4.26.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>picoline&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-6-2">ZT4.26.6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pyridoxal&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YB12e vitamin B complex &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YB12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YB12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>YC16.14.6.14 pyridoxal kinase &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YC16-14-6-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YC16-14-6-14"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-6-2-2">ZT4.26.6.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pyridoxal phosphate&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-6-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">BT</TD><TD>+YD4e coenzymes &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YD4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YD4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-6-4">ZT4.26.6.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pyridoxamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YB12e vitamin B complex &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YB12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YB12"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-8">ZT4.26.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>picolinic acid&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-10">ZT4.26.10</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pyridinium compounds&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-10-2">ZT4.26.10.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>paraquat&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-10-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YX10.4.2 herbicides &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX10-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YX10-4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-10-4">ZT4.26.10.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pyrithiamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-10-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YT4 antimetabolites &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-26-12">ZT4.26.12</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pyrithioxin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">ST</TD><TD> pyritinol </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP4.6e alcohol withdrawal agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-28">ZT4.28</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>pyrimidines&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-28-2">ZT4.28.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>buspirone&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A nonbenzodiazepine anxiolytic.  At present, it is regarded as having negligible dependence potential.  See *+YW4.8 sedative-hypnotics* <A HREF="aodhqy.htm#YW4-8"><SMALL>qh</SMALL></A> <A
   HREF="aodhnyw.htm#YW4-8"><SMALL>ah</SMALL></A>.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP4.8.2.2e serotonergic anti-alcohol-craving agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.8.12.8 agents for alcohol-concurrent anxiety &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-12-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-12-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8e sedative-hypnotics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.6e antianxiety tranquilizers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-28-4">ZT4.28.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pyrimethamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YQ4.10.4.2 antimalarials &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YQ4-10-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YQ4-10-4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-28-6">ZT4.28.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pyrimidinone&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-28-6-2">ZT4.28.6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>risperidone&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
<TR><TD WIDTH="31%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>A dopamine and serotonin antagonist; an antipsychotic agent.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YV6.6e serotonin antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.10.2e antipsychotic tranquilizers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-10-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-28-6-4">ZT4.28.6.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>ritanserin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 1995.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP4.8.2.10 neuropeptide anti-alcohol-craving agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-2-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-2-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV6.6e serotonin antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-28-6-6">ZT4.28.6.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>barbiturates&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A group of central nervous system depressants that chemically are substituted derivatives of barbituric acid; examples are amobarbital, pentobarbital, and secobarbital.  They are used as
   antiepileptics, anesthetics, hypnotics (sleep-inducing), and, less commonly, as anxiolytics or antianxiety drugs. Acute and chronic use induces effects similar to alcohol.  
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Barbiturates have a narrow therapeutic-to-toxic dosage ratio and are often lethal in overdose.  
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Barbiturates are associated with the full range of substance use disorders listed in ICD-10 (they are classed with F13).
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+YW4.8.2e barbiturate sedative-hypnotics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP4.6e alcohol withdrawal agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YR4e anesthetics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YR4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YR4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4e CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.4e general anesthetics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.6e anticonvulsants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+YW4.8e sedative-hypnotics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-28-6-6-4">ZT4.28.6.6.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>amobarbital&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">ST</TD><TD> Amytal </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.6.2 schedule III CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.2.4 intermediate-acting barbiturates &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-28-6-6-6">ZT4.28.6.6.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>barbital&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-6-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">ST</TD><TD> Veronal </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.8.2 schedule IV CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.2.2 long-acting barbiturates &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-28-6-6-8">ZT4.28.6.6.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>murexide&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-6-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-28-6-6-10">ZT4.28.6.6.10</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pentobarbital&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-6-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A short-acting, quick-onset barbiturate.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> pentobarbital sodium </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.4.4 schedule II CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BT6.6.2 schedule III CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP6.6.2 barbiturate withdrawal agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP6-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP6-6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.2.6 short-acting barbiturates &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-2-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-28-6-6-12">ZT4.28.6.6.12</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>phenobarbital&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-6-12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">ST</TD><TD> Luminal </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.8.2 schedule IV CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.6e alcohol withdrawal agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.6.12 anti-alcohol-related-seizures agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6-12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP6.6.2 barbiturate withdrawal agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP6-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP6-6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.2.2 long-acting barbiturates &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-28-6-6-14">ZT4.28.6.6.14</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>primidone&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-6-14"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-28-6-6-16">ZT4.28.6.6.16</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>secobarbital&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-6-16"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">ST</TD><TD> secobarbital sodium </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> Seconal </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.6.2 schedule III CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.2.6 short-acting barbiturates &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-2-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-28-6-6-18">ZT4.28.6.6.18</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>thiobarbiturates&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-6-18"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-28-6-6-18-4">ZT4.28.6.6.18.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>thiopental&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-6-18-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD><TD WIDTH="5%">ST</TD><TD> Nembutal </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> Pentothal </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> thiopental sodium </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YW4.8.2.6 short-acting barbiturates &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-2-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-28-6-8">ZT4.28.6.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>uracil&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-28-6-8-2">ZT4.28.6.8.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>thiouracil&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">BT</TD><TD>+YG34.6 thyroid antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YG34-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YG34-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YT4 antimetabolites &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-28-6-8-2-2">ZT4.28.6.8.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>propylthiouracil&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-8-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD><TD WIDTH="5%">BT</TD><TD>+YT4 antimetabolites &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-30">ZT4.30</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>pyrrole&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-30"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-30-2">ZT4.30.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>porphyrins&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-30-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">NT</TD><TD>+GR16 porphyrin disorder &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GR16"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngo.htm#GR16"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YZ10 pigments and dyes &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YZ10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-30-2-2">ZT4.30.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>porphyrinogens&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-30-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YZ10 pigments and dyes &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YZ10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-30-2-4">ZT4.30.2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>protoporphyrins&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-30-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YZ10 pigments and dyes &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YZ10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-30-2-6">ZT4.30.2.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>uroporphyrins&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-30-2-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YZ10 pigments and dyes &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YZ10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-30-4">ZT4.30.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>bilirubin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-30-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A tetrapyrrole bile pigment derived from the metabolism of porphyrins.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YZ10 pigments and dyes &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YZ10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+GR18 hyperbilirubinemia &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GR18"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngo.htm#GR18"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>HG12.8e liver function test &nbsp;&nbsp;&nbsp;<A HREF="aodhqha.htm#HG12-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnha.htm#HG12-8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-30-4-2">ZT4.30.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>biliverdin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-30-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YZ10 pigments and dyes &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YZ10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-30-6">ZT4.30.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>urobilin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-30-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YZ10 pigments and dyes &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YZ10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-30-8">ZT4.30.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>urobilinogen&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-30-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YZ10 pigments and dyes &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YZ10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>HG12.8e liver function test &nbsp;&nbsp;&nbsp;<A HREF="aodhqha.htm#HG12-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnha.htm#HG12-8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-30-10">ZT4.30.10</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>porphobilinogen&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-30-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-30-12">ZT4.30.12</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>tolmetin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-30-12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YQ2.2 nonsteroidal anti-inflammatory drugs &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YQ2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YQ2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YR2.2 nonnarcotic analgesics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YR2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YR2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-32">ZT4.32</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>pyrrolidine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-32"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-32-2">ZT4.32.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>dipyrrolidine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-32-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-32-2-2">ZT4.32.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>tremorine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-32-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YV10.4 ganglionic stimulants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV10-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-32-4">ZT4.32.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>kainate&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-32-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> kainic acid </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YQ4.10 antiparasitic agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YQ4-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YQ4-10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-32-6">ZT4.32.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pyrrolidinone&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-32-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZN2.20.2.2.2e piracetam &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-2-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-20-2-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZN6.2e succinimide &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN6-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-32-6-2">ZT4.32.6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>oxotremorine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-32-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YV10.4 ganglionic stimulants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV10-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-34">ZT4.34</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>thiazine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-34"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-34-2">ZT4.34.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>piroxicam&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-34-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YQ2.2 nonsteroidal anti-inflammatory drugs &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YQ2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YQ2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YR2.2 nonnarcotic analgesics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YR2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YR2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-36">ZT4.36</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>thiazole&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-36"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-36-2">ZT4.36.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>famotidine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-36-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YT10.8 antiulcer agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT10-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT10-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV6.4.4e histamine H2 receptor blockaders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-4-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT4-38">ZT4.38</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>cimetidine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-38"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">BT</TD><TD>+YT10.8 antiulcer agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT10-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT10-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YT10.14 antisecretory agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT10-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT10-14"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV6.4.4e histamine H2 receptor blockaders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-4-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6"><B>ZT6</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>2-ring heterocyclic compounds</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-2">ZT6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>cocaethylene&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
<TR><TD WIDTH="27%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Cocaethylene is a psychoactive ethyl homologue of cocaine and is formed exclusively during the coadministration of cocaine and alcohol.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> benzoylecgonine ethyl ester </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BP6 alcohol and cocaine &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BP6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BP6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EB10.12e ethanol metabolism &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EB10-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EB10-12"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4">ZT6.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>benzazepines&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2">ZT6.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>benzodiazepines&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>One of a group of structurally related drugs used mainly as antianxiety drugs, sedative/hypnotics, muscle relaxants, and antiepileptics.  Also known as minor tranquilizers (deprecated) and
   anxiolytics.  
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Benzodiazepines are frequently misused in conjunction with alcohol or opioid dependence.  See *AA2.6 multiple drug use* <A
   HREF="aodhqa.htm#AA2-6"><SMALL>qh</SMALL></A> <A HREF="aodhna.htm#AA2-6"><SMALL>ah</SMALL></A>.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+YP4.6.8e benzodiazepines for alcohol withdrawal &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP4.8.12.8 agents for alcohol-concurrent anxiety &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-12-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-12-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>YK10e benzodiazepine receptors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YK10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4e CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.6.2 benzodiazepine tranquilizers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZJ2.6.10.2.2.2e GABA &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-6-10-2-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-6-10-2-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-2">ZT6.4.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>alprazolam&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+BT6.8.2 schedule IV CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.6.8e benzodiazepines for alcohol withdrawal &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.8.12.8 agents for alcohol-concurrent anxiety &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-12-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-12-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.6.2.2 short-acting benzodiazepines &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-6-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-6-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-4">ZT6.4.2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>RO 15-4513&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">ST</TD><TD> imidazobenzodiazepine </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-6">ZT6.4.2.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>carbamazepin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YP10.8.2 anti-cocaine-craving agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP10-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP10-8-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-8">ZT6.4.2.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>benzodiazepinones&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-8-2">ZT6.4.2.8.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>anthramycin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-8-4">ZT6.4.2.8.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>bromazepam&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZT6.4.2.8.30e temazepam &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-30"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-4-2-8-30"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.8.2 schedule IV CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-8-6">ZT6.4.2.8.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>camazepam&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">BT</TD><TD>+BT6.8.2 schedule IV CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-8-8">ZT6.4.2.8.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>clonazepam&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">ST</TD><TD> Klonopin </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.8.2 schedule IV CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.6.8e benzodiazepines for alcohol withdrawal &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6-8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-8-12">ZT6.4.2.8.12</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>diazepam&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">ST</TD><TD> Valium </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.8.2 schedule IV CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.6.8e benzodiazepines for alcohol withdrawal &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP6.6.4 benzodiazepine withdrawal agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP6-6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP6-6-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.6.2.4 long-acting benzodiazepines &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-6-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-6-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-8-12-2">ZT6.4.2.8.12.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>demethyldiazepam&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-12-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-8-14">ZT6.4.2.8.14</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>flumazenil&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-14"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Changed descriptor 1995; through 1995 also use "flumazepil."
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> flumazepil </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> RO 15-1788 </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-8-16">ZT6.4.2.8.16</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>flunitrazepam&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-16"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">ST</TD><TD> Rohypnol </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.8.2 schedule IV CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.6.2.2 short-acting benzodiazepines &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-6-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-6-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-8-18">ZT6.4.2.8.18</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>flurazepam&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-18"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">ST</TD><TD> Dalmane </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> flurazepam hydrochloride </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.8.2 schedule IV CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.6.8e benzodiazepines for alcohol withdrawal &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.6.2.4 long-acting benzodiazepines &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-6-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-6-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-8-20">ZT6.4.2.8.20</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>lorazepam&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-20"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">ST</TD><TD> Ativan </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.8.2 schedule IV CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.6.8e benzodiazepines for alcohol withdrawal &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.6.2.2 short-acting benzodiazepines &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-6-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-6-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-8-22">ZT6.4.2.8.22</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nitrazepam&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-22"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">BT</TD><TD>+BT6.8.2 schedule IV CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.6.2.2 short-acting benzodiazepines &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-6-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-6-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-8-24">ZT6.4.2.8.24</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>oxazepam&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-24"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">ST</TD><TD> Serax </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.8.2 schedule IV CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.6.8e benzodiazepines for alcohol withdrawal &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.6.2.2 short-acting benzodiazepines &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-6-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-6-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-8-26">ZT6.4.2.8.26</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pirenzepine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-26"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-8-28">ZT6.4.2.8.28</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>prazepam&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-28"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">BT</TD><TD>+BT6.8.2 schedule IV CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.6.8e benzodiazepines for alcohol withdrawal &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YT6.2 central muscle relaxants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.6.2.4 long-acting benzodiazepines &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-6-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-6-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-8-30">ZT6.4.2.8.30</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>temazepam&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-30"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">BT</TD><TD>+BT6.8.2 schedule IV CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.6.8e benzodiazepines for alcohol withdrawal &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.6.2.2 short-acting benzodiazepines &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-6-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-6-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT6.4.2.8.4e bromazepam &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-4-2-8-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-8-32">ZT6.4.2.8.32</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>halazepam&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-32"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">BT</TD><TD>+BT6.8.2 schedule IV CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.6.8e benzodiazepines for alcohol withdrawal &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.6.2.2 short-acting benzodiazepines &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-6-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-6-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-8-34">ZT6.4.2.8.34</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>omeprazole&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-34"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">BT</TD><TD>+YT10.8 antiulcer agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT10-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT10-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YT10.14 antisecretory agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT10-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT10-14"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-10">ZT6.4.2.10</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>chlordiazepoxide&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>An antianxiety tranquilizer derived from benzodiazepine.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> chlordiazepoxide hydrochloride </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> Librium </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> methaminodiazepoxide </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.8.2 schedule IV CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.6.8e benzodiazepines for alcohol withdrawal &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.6.2.4 long-acting benzodiazepines &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-6-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-6-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-10-2">ZT6.4.2.10.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>clorazepate&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-10-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">ST</TD><TD> chlorazepate dipotassium </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> Tranxene </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.8.2 schedule IV CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.6.8e benzodiazepines for alcohol withdrawal &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.6.2.4 long-acting benzodiazepines &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-6-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-6-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-12">ZT6.4.2.12</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>midazolam&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+BT6.8.2 schedule IV CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-2-14">ZT6.4.2.14</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>triazolam&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-14"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+BT6.8.2 schedule IV CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.4e nonbarbiturate sedative-hypnotics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.6.2.2 short-acting benzodiazepines &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-6-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-6-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-4-4">ZT6.4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>diltiazem&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-6">ZT6.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>benzimidazoles&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-6-2">ZT6.6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pimozide&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YW4.10.2e antipsychotic tranquilizers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-10-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-8">ZT6.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>benzopyrans&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-8-2">ZT6.8.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>chroman&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>BJ4.2e catechin &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BJ4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BJ4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-8-2-2">ZT6.8.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>flavones&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-8-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YB8e flavonoids &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YB8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YB8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+YZ10 pigments and dyes &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YZ10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-8-2-2-2">ZT6.8.2.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>isoflavonoids&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-8-2-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> isoflavones </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-8-2-2-2-2">ZT6.8.2.2.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>daidzin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-8-2-2-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
<TR><TD WIDTH="35%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Extracted from plant Pueraria lobata or kudzu root (radix puerariae).
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> daidzein </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP4.2e anti-alcohol-intoxication agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.8.2e anti-alcohol-craving agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-8-2-2-2-4">ZT6.8.2.2.2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>puerarin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-8-2-2-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
<TR><TD WIDTH="35%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Extracted from plant Pueraria lobata or kudzu root (radix puerariae).
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP4.2e anti-alcohol-intoxication agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.8.2e anti-alcohol-craving agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-8-4">ZT6.8.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>coumarin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-8-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 1995.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-8-4-2">ZT6.8.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>4-hydroxycoumarin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-8-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-8-4-2-2">ZT6.8.4.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>warfarin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-8-4-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">BT</TD><TD>+YX10.4.8 rodenticides &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX10-4-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YX10-4-8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-10">ZT6.10</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>indoles&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZP10e ibogaine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-10-2">ZT6.10.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>hydroxytryptophol&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-10-2-2">ZT6.10.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>5-hydroxytryptophol&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> 5-HTOL </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+HB4.6.2.8.2 alcohol-related biochemical markers &nbsp;&nbsp;&nbsp;<A HREF="aodhqha.htm#HB4-6-2-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnha.htm#HB4-6-2-8-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-10-4">ZT6.10.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>indoleacetic acid&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ZT2 heterocyclic acid &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-10-4-2">ZT6.10.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>hydroxyindoleacetic acid&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> 5-HIAA </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> 5-hydroxyindoleacetic acid </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> HIAA </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-10-6">ZT6.10.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>indomethacin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YQ2.2 nonsteroidal anti-inflammatory drugs &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YQ2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YQ2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YR2.2.6 gout suppressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YR2-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YR2-2-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-10-8">ZT6.10.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>oxyphenisatin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-10-10">ZT6.10.10</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>melanin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YZ10 pigments and dyes &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YZ10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>XH2.2.2e melanocyte &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XH2-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XH2-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZN2.8.4e dopa &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-8-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-10-12">ZT6.10.12</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>tryptamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10-12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Nonhallucinogenic chemical from which the hallucinogenic drugs dimethyltryptamine (DMT), LSD, and psilocybin can be derived.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>BF8.4 psilocybine &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BF8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BF8-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>YH2.2.2e melatonin &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YH2-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YH2-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ZN2.18.2.2e biogenic monoamines &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-18-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-10-12-2">ZT6.10.12.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>N,N-Dimethyltryptamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10-12-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
<TR><TD WIDTH="31%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>An N-methylated indoleamine derivative, a serotonergic hallucinogen found in several plants, especially Prestonia amazonica (Apocynaceae) and in mammalian brain, blood, and urine. It apparently acts
   as an agonist at some types of serotonin receptors and an antagonist at others.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> 3-(2-(Dimethylamino)ethyl)indole </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YV6.6e serotonin antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-10-12-4">ZT6.10.12.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>serotonin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10-12-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">ST</TD><TD> 5-HT </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> 5-hydroxytryptamine </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> hydroxytryptamine </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YJ2e neurotransmitters &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YJ2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YJ2.4e monoamine neurotransmitters &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YJ2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YM14 slow-reacting substances &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YM14"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV4 neuroregulators &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZN2e amines &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>YK6.10.4e serotonin receptors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK6-10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YK6-10-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YL6e antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YL6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YL6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV6.6e serotonin antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-12">ZT6.12</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>isoquinolines&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZP2e bicuculline &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZP24e salsoline alkaloids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP24"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP24"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ12.2e papaverine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ12-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ZG2.4e acetaldehyde &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZG2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZG2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-12-2">ZT6.12.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>emetine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-12-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YP4.8.10e conditioned alcohol aversion agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+HK2.12.2e chemical aversion therapy &nbsp;&nbsp;&nbsp;<A HREF="aodhqhj.htm#HK2-12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnhj.htm#HK2-12-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-12-6">ZT6.12.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nomifensine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-12-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YV4.2 dopaminergic agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW6e antidepressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-12-8">ZT6.12.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>beta-carboline&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-12-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-14">ZT6.14</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>penicillinic acid&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-14"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-16">ZT6.16</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>pteridine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-16"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-18">ZT6.18</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>purines&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-18"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-18-2">ZT6.18.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>purinone&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-18-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-18-2-2">ZT6.18.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>xanthines&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-18-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">NT</TD><TD>+ZP28e xanthine alkaloids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP28"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP28"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YW8e CNS stimulants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>YC14.12.4e xanthine dehydrogenase &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YC14-12-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YC14-12-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>YC14.12.6e xanthine oxidase &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YC14-12-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YC14-12-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-18-4">ZT6.18.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>flavins&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-18-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>YB12.20e riboflavin &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YB12-20"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YB12-20"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YZ10 pigments and dyes &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YZ10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+YB8e flavonoids &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YB8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YB8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-18-4-2">ZT6.18.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>uric acid&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-18-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-20">ZT6.20</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>quinazolines&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-20"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-20-2">ZT6.20.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>ketanserin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-20-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YT14.6 platelet aggregation inhibitors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT14-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT14-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV6.6e serotonin antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-20-4">ZT6.20.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>methaqualone&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-20-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Nonbarbiturate sedative-hypnotic that produces sleep for about 6 to 8 hours, originally marketed as an alternative to barbiturates.  When taken in large doses for purposes other than sleep
   inducement, it produces muscular relaxation, feelings of contentment, and total passivity, a state somewhat resembling drunkenness.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> Quaalude </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.2.4 schedule I CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.4e nonbarbiturate sedative-hypnotics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-20-6">ZT6.20.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>prazosin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-20-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YT8.8 antihypertensive agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV12.2e alpha-adrenergic receptor blockaders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV12-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-22">ZT6.22</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>quinolines&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-22"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZP4.2e quinidine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZP4.4e quinine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP4-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-22-2">ZT6.22.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>quipazines&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-22-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-24">ZT6.24</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>quinolones&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-24"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT6-24-2">ZT6.24.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>ciprofloxacin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-24-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YQ4.6 antibacterial agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YQ4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YQ4-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8"><B>ZT8</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>3-ring heterocyclic compounds</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-2">ZT8.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>acridines&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-2-2">ZT8.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>aminoacridine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-2-2-2">ZT8.2.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>quinacrine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-2-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YD8.2 ADH antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YD8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YD8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YQ4.10.4.2 antimalarials &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YQ4-10-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YQ4-10-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YQ6 antineoplastic agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YQ6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YQ6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-2-2-4">ZT8.2.2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>imipramine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-2-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">ST</TD><TD> imipramine hydrochloride </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP4.8.12.6 agents for alcohol-concurrent depression &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-12-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-12-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.8.12.8 agents for alcohol-concurrent anxiety &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-12-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-12-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP10.8.6 cocaine blockers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP10-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP10-8-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP10.8.10.2 agents for cocaine-concurrent depression &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP10-8-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP10-8-10-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW6.2 tricyclic antidepressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW6-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-2-2-6">ZT8.2.2.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>desipramine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-2-2-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">ST</TD><TD> desmethylimipramine </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP4.8.12.6 agents for alcohol-concurrent depression &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-12-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-12-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP10.8.2 anti-cocaine-craving agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP10-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP10-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP10.8.10.2 agents for cocaine-concurrent depression &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP10-8-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP10-8-10-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP10.8.10.4 agents for cocaine-concurrent anxiety &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP10-8-10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP10-8-10-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW6.2 tricyclic antidepressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW6-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-2-2-8">ZT8.2.2.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>trimipramine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-2-2-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-4">ZT8.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>dibenzazepines&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-4-2">ZT8.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>carbamazepine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">ST</TD><TD> Depakene </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> Depakote </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> Tegretol </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP4.6e alcohol withdrawal agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.6.12 anti-alcohol-related-seizures agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6-12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP10.8 cocaine relapse prevention agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP10-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP10-8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-4-2-2">ZT8.4.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>clozapine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-4-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YV6.6e serotonin antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.10.2e antipsychotic tranquilizers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-10-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-4-2-4">ZT8.4.2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>clomipramine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-4-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-6">ZT8.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>dibenzoxazepines&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-6-2">ZT8.6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>loxapine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-6-2-2">ZT8.6.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>amoxapine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-6-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YV6.6.2e serotonin uptake inhibitors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-6-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-8">ZT8.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>dibenzoxepins&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-8-2">ZT8.8.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>doxepin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YP4.8.12.6 agents for alcohol-concurrent depression &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-12-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-12-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP10.8.10.2 agents for cocaine-concurrent depression &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP10-8-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP10-8-10-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.6e antianxiety tranquilizers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-8-4">ZT8.8.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>harmine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-8-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YW10e hallucinogens &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZPe alkaloids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-10">ZT8.10</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>phenanthroline&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-12">ZT8.12</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>phenazine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-12-2">ZT8.12.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>thiothixene&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-12-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YW4.10.2e antipsychotic tranquilizers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-10-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-14">ZT8.14</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>phenothiazine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-14"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-14-2">ZT8.14.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>chlorpromazine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-14-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> Thorazine </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YW4.10.2.4 phenothiazine tranquilizers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-10-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-10-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-14-4">ZT8.14.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>perphenazine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-14-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YW4.10.2.4 phenothiazine tranquilizers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-10-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-10-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-14-6">ZT8.14.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>prochlorperazine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-14-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YW4.10.2.4 phenothiazine tranquilizers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-10-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-10-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-14-8">ZT8.14.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>promazine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-14-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YW4.10.2.4 phenothiazine tranquilizers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-10-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-10-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-14-10">ZT8.14.10</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>promethazine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-14-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">ST</TD><TD> promethazine hydrochloride </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YV6.2 antiemetics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV6.4.2e histamine H1 receptor blockaders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZN2.4e propylamine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-14-12">ZT8.14.12</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>thioridazine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-14-12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YP4.8.12.2 dopaminergic blockers for alcohol-concurrent mental disorders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-12-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.10.2.4 phenothiazine tranquilizers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-10-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-10-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-14-14">ZT8.14.14</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>trifluoperazine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-14-14"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YW4.10.2.4 phenothiazine tranquilizers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-10-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-10-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-16">ZT8.16</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>xanthene&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-16"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-16-2">ZT8.16.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>thioxanthene&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-16-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT8-16-2-2">ZT8.16.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>flupenthixol&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-16-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YP10.8 cocaine relapse prevention agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP10-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP10-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP10.8.2 anti-cocaine-craving agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP10-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP10-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.10.2e antipsychotic tranquilizers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-10-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT4.18e piperazine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-18"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-18"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT10"><B>ZT10</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>4 or more ring heterocyclic compounds</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">ST</TD><TD> 4-ring or more heterocyclic compounds </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+ZQ4 phenanthrene derivative opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ZP8 ergot alkaloids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT10-2">ZT10.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>yohimban&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT10-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZP26.2e reserpine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP26-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP26-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZP26.4e yohimbine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP26-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP26-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ZP26e rauwolfia alkaloids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP26"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP26"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT12"><B>ZT12</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>bridged-ring heterocyclic compounds</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZQ4.6.4e naloxone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-6-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.6.6e naltrexone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-6-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZT12-2">ZT12.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>quinuclidine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT12-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZJ2.10.4.4.2e quinuclidinyl benzilate &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-10-4-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-10-4-4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
</TABLE><BR><BR>
<CENTER><A HREF="aodob.htm#Z">b-out</A>&nbsp;&nbsp;To Broad Outline&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#ZT">d-out</A>&nbsp;&nbsp;To Detailed Outline&nbsp;&nbsp;&nbsp;&nbsp;
<A HREF="aodhqz.htm">qh</A>&nbsp;&nbsp;To Quick Hierarchy</CENTER>
<CENTER><A HREF="aodhnzr.htm">Previous</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodhnzu.htm">Next</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodwsrch.htm">Search</A></CENTER><P>classification thesaurus glossary dictionary definition subject heading list ontology vocabulary knowledge structure knowledge organization terminology concept </P>
</BODY>
</HTML>
